Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride

View through CrossRef
Raloxifene is a drug used in postmenopausal women with osteoporosis. Although hot flashes are known side effects of raloxifene, to the best of our knowledge, erythema multiforme (EM) minor has not been previously reported. Herein, we report about a 74-year-old woman who developed EM minor after the drug alfacalcidol was changed to raloxifene to treat osteoporosis. Skin biopsy revealed a suspicious eczematous drug reaction. The drug-induced lymphocyte stimulation test showed a positive result. The stimulation index was 2.2, and there were no other suspected drugs. Based on these results, we diagnosed the condition as EM minor caused by raloxifene. The patient’s symptoms disappeared after the use of antihistamine drugs and topical steroids. In conclusion, raloxifene can cause EM minor in rare cases.
Title: First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
Description:
Raloxifene is a drug used in postmenopausal women with osteoporosis.
Although hot flashes are known side effects of raloxifene, to the best of our knowledge, erythema multiforme (EM) minor has not been previously reported.
Herein, we report about a 74-year-old woman who developed EM minor after the drug alfacalcidol was changed to raloxifene to treat osteoporosis.
Skin biopsy revealed a suspicious eczematous drug reaction.
The drug-induced lymphocyte stimulation test showed a positive result.
The stimulation index was 2.
2, and there were no other suspected drugs.
Based on these results, we diagnosed the condition as EM minor caused by raloxifene.
The patient’s symptoms disappeared after the use of antihistamine drugs and topical steroids.
In conclusion, raloxifene can cause EM minor in rare cases.

Related Results

Environmental fate and chemistry of raloxifene hydrochloride
Environmental fate and chemistry of raloxifene hydrochloride
Abstract Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) used for the prevention and treatment of osteoporosis in women. Excretion of ralo...
Effects of Raloxifene on Fracture Risk in Postmenopausal Women: The Raloxifene Use for The Heart Trial
Effects of Raloxifene on Fracture Risk in Postmenopausal Women: The Raloxifene Use for The Heart Trial
Abstract Using data from a randomized placebo-controlled trial of 10,101 postmenopausal women not selected on the basis of osteoporosis, we examined whether the effe...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Abstract 4598: GP130 as a novel therapeutic target in il-6-dependent cancers
Abstract 4598: GP130 as a novel therapeutic target in il-6-dependent cancers
Abstract The IL-6/GP130 signaling pathway is critical for the survival and progression of cancer cells of multiple cancer types. We report here the new discovery of ...
Cardiovascular Effects of Raloxifene Hydrochloride
Cardiovascular Effects of Raloxifene Hydrochloride
ABSTRACTRaloxifene hydrochloride binds to the estrogen receptor and shows tissue‐selective effects; thus, it belongs to a class of drugs recently described asselective estrogen rec...
Intermittent oral cyclosporin for recurrent herpes simplex‐associated erythema multiforme
Intermittent oral cyclosporin for recurrent herpes simplex‐associated erythema multiforme
SUMMARYRecurrent erythema multiforme is one of three distinct clinical subtypes of erythema multiforme. We present a 42‐year‐old man with a 10‐year history of recurrent herpes simp...

Back to Top